Harvey Norman Holdings Limited (ASX:HVN) Reports Profits Down 16% In FY18

Harvey Norman Holdings Limited (ASX:HVN) released its 2018 financial results to the market today revealing a 17.1% fall in profit

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Harvey Norman Holdings Limited (ASX: HVN) released its 2018 financial results to the market today revealing a 17.1% fall in profit

Harvey Norman Holdings is the company responsible for franchising Harvey Norman

online pharmacy seroquel no prescription

outlets across Australia, as well as Domayne.

Here are some of the highlights from its report:

  • Company-operated sales revenue up 8.8% to $2 billion
  • Underlying net profit down 0.1% to $375.38 million
  • Reported net profit down 16.4% to $375.38 million

According to Bell Potter, analysts were expecting Harvey Norman Holdings to report a profit of $366.9 million. With the share price down 2% in early trade, investors appear to be disappointed with the result.

The reported profit was hit by the $49.44 million impairment relating to the dairy farm joint venture, Coomboona.

Harvey Norman’s company-operated overseas retail segment delivered growth. Singapore & Malaysia saw growth of 29.6% to $25.01 million, Ireland & Northern Ireland saw growth of 156.7% to $1.41 million and Slovenia & Croatia generated growth of 60% to $7.4 million.

The Chairman of Harvey Norman, Gerry Harvey, remained positive saying:

We fully intend to capitalise on this excellent performance overseas, and plan to invest substantially in growing our offshore Harvey Normal store network, particularly in South East Asia. We are actively exploring new sites, and there is an expectation to open up to 18 new Harvey Norman company-operated stores overseas in the next two years.”

The Australian Investors Podcast

The Rask Group’s Australian Investors Podcast is fast becoming Australia’s #1 podcast for serious investors. It provides unique insights from Australia’s

online pharmacy order valtrex no prescription with best prices today in the USA

 best investors, entrepreneurs, authors and financial thinkers. Download the latest episode free on iTunesCastboxYouTube or wherever you choose to listen.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.